Trial intelligence / Profile preview

Megestrol Acetate With or Without Pterostilbene in Endometrial Cancer

NCT03671811Phase 2Active, not recruiting

Sponsor
City of Hope
Start
Jan 2019
Primary completion
Dec 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pTeroPure in endometrial cancer (EC), Atypical endometrial hyperplasia (AEH), sponsored by City of Hope. Started Jan 2019; status: active, not recruiting.

02

Drugs

pTeroPure
03

Conditions

endometrial cancer (EC)Atypical endometrial hyperplasia (AEH)

Beyond the preview

Go deeper on NCT03671811.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03671811.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call